Daniel Couto is the founder of Vedanta Biosciences. Vedanta Biosciences has raised $169M in total funding. Latest round: Series D.
Daniel Couto is the COO of Vedanta Biosciences, a leading microbiome company. The company is developing novel therapies that modulate the interaction between the human microbiome and the host immune system. Vedanta Biosciences recently completed a $68 million Series D financing round. Couto has nearly 30 years of experience in advancing biopharmaceutical development and manufacturing organizations.
Full founder directory · Investor directory · Company funding database · Fundraising library